Company Founded
Huayuu Biopharma established in Hangzhou, embarking on the journey of innovation.
Company Overview
HUAYUU supplies peptides, biochemical ingredients and cosmetic actives for global B2B sourcing, with COA, product specifications, bulk supply and selected customization support.
Hangzhou Huayuu Biopharma Co., Ltd. (HUAYUU) supplies peptides, biochemical ingredients and cosmetic actives, with product specifications, COA, bulk supply and selected customization support for international B2B customers.
Global B2B Peptide & Biochemical Ingredient Sourcing HubWelcome to Hangzhou Huayuu Biopharma Co., Ltd. (HUAYUU), your trusted partner for high-purity bulk active ingredients. We support your commercial scale-up and customized R&D with strict quality assurance, comprehensive documentation, and flexible compliance verification.Explore our three core product sectors to download specific COAs and Technical Specifications:Cosmetic Ingredients: High-purity functional actives and bio-peptides engineered for advanced personal care formulations.Peptides: Premium custom and catalog peptide solutions tailored for analytical research and diagnostic applications.Pharmaceutical & Biochemical Ingredients: Premium-grade raw materials and reactive biochem compounds meeting strict global regulatory standards.All batches are fully documented. Request batch-specific COAs, structural data, or free evaluation samples directly within each product section.
Mission & Vision
Our Mission
To develop innovative biopharmaceuticals that safeguard human health and improve quality of life worldwide.
Our Vision
To become a globally recognized biopharmaceutical leader, driving innovation from bench to bedside.
Core Values
- Innovation - Continuously exploring cutting-edge technology to lead industry development
- Integrity - Treating people with sincerity, establishing business with trust
- Excellence - Pursuing superior quality, creating first-class products
- Patient-Centricity - Everything for patient health and well-being
Our Journey
Milestones of Growth and Innovation
2015
2018
First Patent
Granted first national invention patent for cell engineering.
2020
Provincial R&D Center
Established provincial-level enterprise technology center.
2022
Postdoctoral Station
Approved as postdoctoral research workstation.
2024
Series B Funding
Completed Series B funding of 500 million RMB.
2025
IND Filing
Two antibody drug candidates entered IND filing stage.
Learn More
Explore Huayu's products, research team, and partnership opportunities